Interleukin-6 trans-signaling is a candidate mechanism to drive progression of human DCCs during clinical latency
暂无分享，去创建一个
N. Harbeck | S. Rose-John | M. Hoffmann | C. Klein | J. Warfsmann | Xin Lu | B. Rack | M. Werner-Klein | S. Treitschke | C. Botteron | S. Huber | Z. Czyż | B. Polzer | C. Werno | K. Weidele | P. Rümmele | Miodrag Gužvić | Giancarlo Feliciello | E. Schneider | S. Buchholz | I. Blochberger | N. Heine | M. Obradović | Ana Grujovic | Christoph Irlbeck | Huiqin Koerkel-Qu | C. Köstler | Stefan Kirsch | K. Honarnejad | Sandra Grunewald | G. Haunschild | N. Patwary | Severin Guetter | Martin Hoffmann | Kamran Honarnejad | Sandra Huber